EDGAR Filing Documents for 0001558370-22-017797

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001558370-22-017797

Filing Date

2022-11-14

Accepted

2022-11-14 16:34:30

Documents

Period of Report

2022-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	idra-20220930x10q.htm iXBRL	10-Q	2006373
2	EX-2.2	idra-20220930xex2d2.htm	EX-2.2	402950
3	EX-10.7	idra-20220930xex10d7.htm	EX-10.7	80369
4	EX-10.8	idra-20220930xex10d8.htm	EX-10.8	394420
5	EX-10.9	idra-20220930xex10d9.htm	EX-10.9	30178
6	EX-10.10	idra-20220930xex10d10.htm	EX-10.10	280105
7	EX-10.11	idra-20220930xex10d11.htm	EX-10.11	82992
8	EX-10.12	idra-20220930xex10d12.htm	EX-10.12	590814
9	EX-10.13	idra-20220930xex10d13.htm	EX-10.13	43125
10	EX-10.14	idra-20220930xex10d14.htm	EX-10.14	386285
11	EX-10.15	idra-20220930xex10d15.htm	EX-10.15	17424
12	EX-31.1	idra-20220930xex31d1.htm	EX-31.1	13870
13	EX-31.2	idra-20220930xex31d2.htm	EX-31.2	13598
14	EX-32.1	idra-20220930xex32d1.htm	EX-32.1	7133
15	EX-32.2	idra-20220930xex32d2.htm	EX-32.2	7760
16	GRAPHIC	idra-20220930x10q004.jpg	GRAPHIC	6453
17	GRAPHIC	idra-20220930xex10d11001.jpg	GRAPHIC	11784
18	GRAPHIC	idra-20220930xex10d13002.jpg	GRAPHIC	4537
19	GRAPHIC	idra-20220930xex10d13001.jpg	GRAPHIC	5259
	Complete submission text file	0001558370-22-017797.txt		11631589

Data Files

Seq	Description	Document	Type	Size
20	EX-101.SCH	idra-20220930.xsd	EX-101.SCH	66029
21	EX-101.CAL	idra-20220930_cal.xml	EX-101.CAL	55373
22	EX-101.DEF	idra-20220930_def.xml	EX-101.DEF	295834
23	EX-101.LAB	idra-20220930_lab.xml	EX-101.LAB	502637
24	EX-101.PRE	idra-20220930_pre.xml	EX-101.PRE	450432
86	EXTRACTED XBRL INSTANCE DOCUMENT	idra-20220930x10q_htm.xml	XML	1637931

Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341

Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600

IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)